India, June 18 -- Aurora Cannabis Inc. (ACB,ACB.TO), a Canadian medical cannabis company, reported Wednesday narrower net loss in its fourth quarter, and adjusted EBITDA surged from last year with higher revenues.
In the pre-market activity on the Nasdaq, Aurora shares were losing around 10.5 percent to trade at $5.26.
Net loss from continuing operations was $17.23 million, compared to a net loss of $20.327 million for the prior year period.
Adjusted EBITDA increased 619 percent to $16.68 million from $2.32 million a year ago. Consolidated adjusted gross margin before fair value adjustments was 62 percent, compared to 50 percent in the prior year period.
Total net revenue was $90.5 million, 34 percent higher than $67.4 million in the pr...